Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links

Neuroscience

Volumn 321, Issue , 2016, Pages 3-23

  Hulbert, S W ^a   Jiang, Y H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autism mouse models; Fmr1; Mecp2; Pten; Shank3; Ube3a

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FRAGILE X MENTAL RETARDATION PROTEIN; NEUREXIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUBERIN;

AUTISM; BRAIN CORTEX; BRAIN REGION; COPY NUMBER VARIATION; EPIGENETICS; EXON; GENE; GENE DELETION; GENE MUTATION; HIPPOCAMPAL CA1 REGION; HUMAN; MECP2 GENE; NONHUMAN; NUCLEUS ACCUMBENS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; SOMATOSENSORY CORTEX; TRANSCRIPTION REGULATION; VENTRAL TEGMENTUM; ANIMAL; BRAIN; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; MUTATION; PSYCHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTISM SPECTRUM DISORDER; BRAIN; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; MICE, MUTANT STRAINS; MUTATION; SIGNAL TRANSDUCTION;

EID: 84953432659     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.12.040     Document Type: Review

References (243)

1. Alarcon M., Abrahams B.S., Stone J.L., Duvall J.A., Perederiy J.V., Bomar J.M., Sebat J., Wigler M., Martin C.L., Ledbetter D.H., Nelson S.F., Cantor R.M., Geschwind D.H. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008, 82:150-159.
2. Albrecht U., Sutcliffe J.S., Cattanach B.M., Beechey C.V., Armstrong D., Eichele G., Beaudet A.L. Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet 1997, 17:75-78.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-5™ 2013, American Psychiatric Publishing Inc, Arlington, VA. 5th ed.
4. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
5. Amiri A., Sanchez-Ortiz E., Cho W., Birnbaum S.G., Xu J., McKay R.M., Parada L.F. Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus. Autism Res 2014, 7:60-71.
6. Argyropoulos A., Gilby K.L., Hill-Yardin E.L. Studying autism in rodent models: reconciling endophenotypes with comorbidities. Front Hum Neurosci 2013, 7:417.
7. Arking D.E., Cutler D.J., Brune C.W., Teslovich T.M., West K., Ikeda M., Rea A., Guy M., Lin S., Cook E.H., Chakravarti A. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008, 82:160-164.
8. Arons M.H., Thynne C.J., Grabrucker A.M., Li D., Schoen M., Cheyne J.E., Boeckers T.M., Montgomery J.M., Garner C.C. Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling. J Neurosci 2012, 32:14966-14978.
9. Asaka Y., Jugloff D.G., Zhang L., Eubanks J.H., Fitzsimonds R.M. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis 2006, 21:217-227.
10. Auerbach B.D., Osterweil E.K., Bear M.F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011, 480:63-68.
11. Bang M.L., Owczarek S. A matter of balance: role of neurexin and neuroligin at the synapse. Neurochem Res 2013, 38:1174-1189.
12. Bassell G.J., Warren S.T. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 2008, 60:201-214.
13. Bateup H.S., Takasaki K.T., Saulnier J.L., Denefrio C.L., Sabatini B.L. Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J Neurosci 2011, 31:8862-8869.
14. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci 2004, 27:370-377.
15. Belichenko P.V., Wright E.E., Belichenko N.P., Masliah E., Li H.H., Mobley W.C., Francke U. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol 2009, 514:240-258.
16. Belmonte M.K., Allen G., Beckel-Mitchener A., Boulanger L.M., Carper R.A., Webb S.J. Autism and abnormal development of brain connectivity. J Neurosci 2004, 24:9228-9231.
17. Belzung C., Lemoine M. Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol Mood Anxiety Disord 2011, 1. 9-5380-1-9.
18. Ben-Shachar S., Chahrour M., Thaller C., Shaw C.A., Zoghbi H.Y. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 2009, 18(13):2431-2442.
19. Berkel S., Marshall C.R., Weiss B., Howe J., Roeth R., Moog U., Endris V., Roberts W., Szatmari P., Pinto D., Bonin M., Riess A., Engels H., Sprengel R., Scherer S.W., Rappold G.A. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 2010, 42:489-491.
20. Bey A.L., Jiang Y.H. Overview of mouse models of autism spectrum disorders. Curr Protoc Pharmacol 2014, 66:5.66.1-5.66.26.
21. Blundell J., Tabuchi K., Bolliger M.F., Blaiss C.A., Brose N., Liu X., Sudhof T.C., Powell C.M. Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes Brain Behav 2009, 8:114-126.
22. Blundell J., Blaiss C.A., Etherton M.R., Espinosa F., Tabuchi K., Walz C., Bolliger M.F., Sudhof T.C., Powell C.M. Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior. J Neurosci 2010, 30:2115-2129.
23. Bonaglia M.C., Giorda R., Borgatti R., Felisari G., Gagliardi C., Selicorni A., Zuffardi O. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet 2001, 69:261-268.
24. Bozdagi O., Sakurai T., Papapetrou D., Wang X., Dickstein D.L., Takahashi N., Kajiwara Y., Yang M., Katz A.M., Scattoni M.L., Harris M.J., Saxena R., Silverman J.L., Crawley J.N., Zhou Q., Hof P.R., Buxbaum J.D. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism 2010, 1. 15-2392-1-15.
25. Braat S., Kooy R.F. Fragile X syndrome neurobiology translates into rational therapy. Drug Discovery Today 2014, 19:510-519.
26. Braat S., Kooy R.F. Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials. Neuropharmacology 2015, 88:48-54.
27. Brouwer J.R., Mientjes E.J., Bakker C.E., Nieuwenhuizen I.M., Severijnen L.A., Van der Linde H.C., Nelson D.L., Oostra B.A., Willemsen R. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Exp Cell Res 2007, 313:244-253.
28. Budreck E.C., Kwon O.B., Jung J.H., Baudouin S., Thommen A., Kim H.S., Fukazawa Y., Harada H., Tabuchi K., Shigemoto R., Scheiffele P., Kim J.H. Neuroligin-1 controls synaptic abundance of NMDA-type glutamate receptors through extracellular coupling. Proc Natl Acad Sci USA 2013, 110:725-730.
29. Buescher A.V., Cidav Z., Knapp M., Mandell D.S. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr 2014, 168:721-728.
30. Butler M.G., Dasouki M.J., Zhou X.P., Talebizadeh Z., Brown M., Takahashi T.N., Miles J.H., Wang C.H., Stratton R., Pilarski R., Eng C. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 2005, 42:318-321.
31. Buxbaum J.D., Cai G., Chaste P., Nygren G., Goldsmith J., Reichert J., Anckarsater H., Rastam M., Smith C.J., Silverman J.M., Hollander E., Leboyer M., Gillberg C., Verloes A., Betancur C. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:484-491.
32. Camacho-Garcia R.J., Hervas A., Toma C., Balmana N., Cormand B., Martinez-Mir A., Scholl F.G. Rare variants analysis of neurexin-1beta in autism reveals a novel start codon mutation affecting protein levels at synapses. Psychiatr Genet 2013, 23:262-266.
33. Cao C., Rioult-Pedotti M.S., Migani P., Yu C.J., Tiwari R., Parang K., Spaller M.R., Goebel D.J., Marshall J. Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biol 2013, 11:e1001478.
34. Castren M.L., Castren E. BDNF in fragile X syndrome. Neuropharmacology 2014, 76 Pt C:729-736.
35. Cellot G., Cherubini E. Reduced inhibitory gate in the barrel cortex of Neuroligin3R451C knock-in mice, an animal model of autism spectrum disorders. Physiol Rep 2014, 2. 10.14814/phy2.12077.
36. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320:1224-1229.
37. Chang Q., Khare G., Dani V., Nelson S., Jaenisch R. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 2006, 49:341-348.
38. Chang J., Gilman S.R., Chiang A.H., Sanders S.J., Vitkup D. Genotype to phenotype relationships in autism spectrum disorders. Nat Neurosci 2015, 18:191-198.
39. Chao H.T., Zoghbi H.Y., Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007, 56:58-65.
40. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., Neul J.L., Gong S., Lu H.C., Heintz N., Ekker M., Rubenstein J.L., Noebels J.L., Rosenmund C., Zoghbi H.Y. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.
41. Chapleau C.A., Boggio E.M., Calfa G., Percy A.K., Giustetto M., Pozzo-Miller L. Hippocampal CA1 pyramidal neurons of Mecp2 mutant mice show a dendritic spine phenotype only in the presymptomatic stage. Neural Plast 2012, 2012:976164.
42. Chaste P., Klei L., Sanders S.J., Hus V., Murtha M.T., Lowe J.K., Willsey A.J., Moreno-De-Luca D., Yu T.W., Fombonne E., Geschwind D., Grice D.E., Ledbetter D.H., Mane S.M., Martin D.M., Morrow E.M., Walsh C.A., Sutcliffe J.S., Lese Martin C., Beaudet A.L., Lord C., State M.W., Cook E.H., Devlin B. A genome-wide association study of autism using the simons simplex collection: does reducing phenotypic heterogeneity in autism increase genetic homogeneity?. Biol Psychiatry 2014.
43. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001, 27:327-331.
44. Chih B., Engelman H., Scheiffele P. Control of excitatory and inhibitory synapse formation by neuroligins. Science 2005, 307:1324-1328.
45. Chung L., Bey A.L., Jiang Y.H. Synaptic plasticity in mouse models of autism spectrum disorders. Korean J Physiol Pharmacol 2012, 16:369-378.
46. Comery T.A., Harris J.B., Willems P.J., Oostra B.A., Irwin S.A., Weiler I.J., Greenough W.T. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 1997, 94:5401-5404.
47. Cook E.H., Lindgren V., Leventhal B.L., Courchesne R., Lincoln A., Shulman C., Lord C., Courchesne E. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 1997, 60:928-934.
48. Courchesne E., Carper R., Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003, 290:337-344.
49. Courchesne E., Campbell K., Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res 2011, 1380:138-145.
50. Crino P.B. Evolving neurobiology of tuberous sclerosis complex. Acta Neuropathol 2013, 125:317-332.
51. Cruz-Martin A., Crespo M., Portera-Cailliau C. Delayed stabilization of dendritic spines in fragile X mice. J Neurosci 2010, 30:7793-7803.
52. Dachtler J., Glasper J., Cohen R.N., Ivorra J.L., Swiffen D.J., Jackson A.J., Harte M.K., Rodgers R.J., Clapcote S.J. Deletion of alpha-neurexin II results in autism-related behaviors in mice. Transl Psychiatry 2014, 4:e484.
53. Dahlhaus R., El-Husseini A. Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome. Behav Brain Res 2010, 208:96-105.
54. Dani V.S., Chang Q., Maffei A., Turrigiano G.G., Jaenisch R., Nelson S.B. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 2005, 102:12560-12565.
55. Darnell J.C., Van Driesche S.J., Zhang C., Hung K.Y., Mele A., Fraser C.E., Stone E.F., Chen C., Fak J.J., Chi S.W., Licatalosi D.D., Richter J.D., Darnell R.B. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146:247-261.
56. Delattre V., La Mendola D., Meystre J., Markram H., Markram K. Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. Sci Rep 2013, 3:2897.
57. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators, Centers for Disease Control and Prevention (CDC) (2014) Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 63:1-21.
58. Devlin B., Scherer S.W. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 2012, 22:229-237.
59. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P.P. Pten is essential for embryonic development and tumour suppression. Nat Genet 1998, 19:348-355.
60. Di Martino A., Yan C.G., Li Q., Denio E., Castellanos F.X., Alaerts K., Anderson J.S., Assaf M., Bookheimer S.Y., Dapretto M., Deen B., Delmonte S., Dinstein I., Ertl-Wagner B., Fair D.A., Gallagher L., Kennedy D.P., Keown C.L., Keysers C., Lainhart J.E., Lord C., Luna B., Menon V., Minshew N.J., Monk C.S., Mueller S., Müller R.A., Nebel M.B., Nigg J.T., O'Hearn K., Pelphrey K.A., Peltier S.J., Rudie J.D., Sunaert S., Thioux M., Tyszka J.M., Uddin L.Q., Verhoeven J.S., Wenderoth N., Wiggins J.L., Mostofsky S.H., Milham M.P. The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism. Mol Psychiatry 2014, 19:659-667.
61. Dindot S.V., Antalffy B.A., Bhattacharjee M.B., Beaudet A.L. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet 2008, 17:111-118.
62. Dolen G., Osterweil E., Rao B.S., Smith G.B., Auerbach B.D., Chattarji S., Bear M.F. Correction of fragile X syndrome in mice. Neuron 2007, 56:955-962.
63. Duffney L.J., Wei J., Cheng J., Liu W., Smith K.R., Kittler J.T., Yan Z. Shank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanism. J Neurosci 2013, 33:15767-15778.
64. Duffney L.J., Zhong P., Wei J., Matas E., Cheng J., Qin L., Ma K., Dietz D.M., Kajiwara Y., Buxbaum J.D., Yan Z. Autism-like deficits in Shank3-deficient mice are rescued by targeting actin regulators. Cell Rep 2015, 11:1400-1413.
65. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsater H., Sponheim E., Goubran-Botros H., Delorme R., Chabane N., Mouren-Simeoni M.C., de Mas P., Bieth E., Roge B., Heron D., Burglen L., Gillberg C., Leboyer M., Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007, 39:25-27.
66. El-Kordi A., Winkler D., Hammerschmidt K., Kastner A., Krueger D., Ronnenberg A., Ritter C., Jatho J., Radyushkin K., Bourgeron T., Fischer J., Brose N., Ehrenreich H. Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behav Brain Res 2013, 251:41-49.
67. Eng C. PTEN: one gene, many syndromes. Hum Mutat 2003, 22:183-198.
68. Etherton M.R., Blaiss C.A., Powell C.M., Sudhof T.C. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci USA 2009, 106:17998-18003.
69. Etherton M., Foldy C., Sharma M., Tabuchi K., Liu X., Shamloo M., Malenka R.C., Sudhof T.C. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc Natl Acad Sci USA 2011, 108:13764-13769.
70. European Chromosome 16 Tuberous Sclerosis Consortium Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993, 75:1305-1315.
71. Ey E., Torquet N., Le Sourd A.M., Leblond C.S., Boeckers T.M., Faure P., Bourgeron T. The autism ProSAP1/Shank2 mouse model displays quantitative and structural abnormalities in ultrasonic vocalisations. Behav Brain Res 2013, 256:677-689.
72. Felix-Ortiz A.C., Tye K.M. Amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior. J Neurosci 2014, 34:586-595.
73. Feng J., Schroer R., Yan J., Song W., Yang C., Bockholt A., Cook E.H., Skinner C., Schwartz C.E., Sommer S.S. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 2006, 409:10-13.
74. Fingar D.C., Salama S., Tsou C., Harlow E., Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 2002, 16:1472-1487.
75. Foldy C., Malenka R.C., Sudhof T.C. Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 2013, 78:498-509.
76. Fombonne E., Roge B., Claverie J., Courty S., Fremolle J. Microcephaly and macrocephaly in autism. J Autism Dev Disord 1999, 29:113-119.
77. Fraser M.M., Bayazitov I.T., Zakharenko S.S., Baker S.J. Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience 2008, 151:476-488.
78. Fukuda T., Itoh M., Ichikawa T., Washiyama K., Goto Y. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 2005, 64:537-544.
79. Gauthier J., Siddiqui T.J., Huashan P., Yokomaku D., Hamdan F.F., Champagne N., Lapointe M., Spiegelman D., Noreau A., Lafreniere R.G., Fathalli F., Joober R., Krebs M.O., DeLisi L.E., Mottron L., Fombonne E., Michaud J.L., Drapeau P., Carbonetto S., Craig A.M., Rouleau G.A. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet 2011, 130:563-573.
80. Gemelli T., Berton O., Nelson E.D., Perrotti L.I., Jaenisch R., Monteggia L.M. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol Psychiatry 2006, 59:468-476.
81. Geschwind D.H., Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 2007, 17:103-111.
82. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., Zhang H., Estes A., Brune C.W., Bradfield J.P., Imielinski M., Frackelton E.C., Reichert J., Crawford E.L., Munson J., Sleiman P.M., Chiavacci R., Annaiah K., Thomas K., Hou C., Glaberson W., Flory J., Otieno F., Garris M., Soorya L., Klei L., Piven J., Meyer K.J., Anagnostou E., Sakurai T., Game R.M., Rudd D.S., Zurawiecki D., McDougle C.J., Davis L.K., Miller J., Posey D.J., Michaels S., Kolevzon A., Silverman J.M., Bernier R., Levy S.E., Schultz R.T., Dawson G., Owley T., McMahon W.M., Wassink T.H., Sweeney J.A., Nurnberger J.I., Coon H., Sutcliffe J.S., Minshew N.J., Grant S.F., Bucan M., Cook E.H., Buxbaum J.D., Devlin B., Schellenberg G.D., Hakonarson H. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
83. Godfraind J.M., Reyniers E., De Boulle K., D'Hooge R., De Deyn P.P., Bakker C.E., Oostra B.A., Kooy R.F., Willems P.J. Long-term potentiation in the hippocampus of fragile X knockout mice. Am J Med Genet 1996, 64:246-251.
84. Grabrucker A.M., Knight M.J., Proepper C., Bockmann J., Joubert M., Rowan M., Nienhaus G.U., Garner C.C., Bowie J.U., Kreutz M.R., Gundelfinger E.D., Boeckers T.M. Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J 2011, 30:569-581.
85. Graf E.R., Zhang X., Jin S.X., Linhoff M.W., Craig A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119:1013-1026.
86. Grayton H.M., Missler M., Collier D.A., Fernandes C. Altered social behaviours in neurexin 1alpha knockout mice resemble core symptoms in neurodevelopmental disorders. PLoS One 2013, 8:e67114.
87. Greer P.L., Hanayama R., Bloodgood B.L., Mardinly A.R., Lipton D.M., Flavell S.W., Kim T.K., Griffith E.C., Waldon Z., Maehr R., Ploegh H.L., Chowdhury S., Worley P.F., Steen J., Greenberg M.E. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 2010, 140:704-716.
88. Gunaydin L.A., Grosenick L., Finkelstein J.C., Kauvar I.V., Fenno L.E., Adhikari A., Lammel S., Mirzabekov J.J., Airan R.D., Zalocusky K.A., Tye K.M., Anikeeva P., Malenka R.C., Deisseroth K. Natural neural projection dynamics underlying social behavior. Cell 2014, 157:1535-1551.
89. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001, 27:322-326.
90. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
91. Hagerman R., Hoem G., Hagerman P. Fragile X and autism: intertwined at the molecular level leading to targeted treatments. Mol Autism 2010, 1. 12-2392-1-12.
92. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., Miller J., Fedele A., Collins J., Smith K., Lotspeich L., Croen L.A., Ozonoff S., Lajonchere C., Grether J.K., Risch N. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011, 68:1095-1102.
93. Haws M.E., Jaramillo T.C., Espinosa F., Widman A.J., Stuber G.D., Sparta D.R., Tye K.M., Russo S.J., Parada L.F., Stavarache M., Kaplitt M., Bonci A., Powell C.M. PTEN knockdown alters dendritic spine/protrusion morphology, not density. J Comp Neurol 2014, 522:1171-1190.
94. Hayrapetyan V., Castro S., Sukharnikova T., Yu C., Cao X., Jiang Y.H., Yin H.H. Region-specific impairments in striatal synaptic transmission and impaired instrumental learning in a mouse model of Angelman syndrome. Eur J Neurosci 2014, 39:1018-1025.
95. He C.X., Portera-Cailliau C. The trouble with spines in fragile X syndrome: density, maturity and plasticity. Neuroscience 2013, 251:120-128.
96. Hoeffer C.A., Klann E. MTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 2010, 33:67-75.
97. Hogart A., Wu D., LaSalle J.M., Schanen N.C. The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13. Neurobiol Dis 2010, 38:181-191.
98. Howlin P., Goode S., Hutton J., Rutter M. Adult outcome for children with autism. J Child Psychol Psychiatry 2004, 45:212-229.
99. Huber K.M., Gallagher S.M., Warren S.T., Bear M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 2002, 99:7746-7750.
100. Huibregtse J.M., Scheffner M., Howley P.M. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol 1993, 13:775-784.
101. Hung A.Y., Futai K., Sala C., Valtschanoff J.G., Ryu J., Woodworth M.A., Kidd F.L., Sung C.C., Miyakawa T., Bear M.F., Weinberg R.J., Sheng M. Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci 2008, 28:1697-1708.
102. Ichtchenko K., Nguyen T., Sudhof T.C. Structures, alternative splicing, and neurexin binding of multiple neuroligins. J Biol Chem 1996, 271:2676-2682.
103. Inoki K., Li Y., Zhu T., Wu J., Guan K.L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002, 4:648-657.
104. Isshiki M., Tanaka S., Kuriu T., Tabuchi K., Takumi T., Okabe S. Enhanced synapse remodelling as a common phenotype in mouse models of autism. Nat Commun 2014, 5:4742.
105. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003, 34:27-29. Paris Autism Research International Sibpair Study.
106. Jamain S., Radyushkin K., Hammerschmidt K., Granon S., Boretius S., Varoqueaux F., Ramanantsoa N., Gallego J., Ronnenberg A., Winter D., Frahm J., Fischer J., Bourgeron T., Ehrenreich H., Brose N. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci USA 2008, 105:1710-1715.
107. Jaramillo T.C., Liu S., Pettersen A., Birnbaum S.G., Powell C.M. Autism-related neuroligin-3 mutation alters social behavior and spatial learning. Autism Res 2014, 7:264-272.
108. Jaramillo T.C., Speed H.E., Xuan Z., Reimers J.M., Liu S., Powell C.M. Altered striatal synaptic function and abnormal behaviour in Shank3 exon4-9 deletion mouse model of autism. Autism Res 2015.
109. Jedlicka P., Vnencak M., Krueger D.D., Jungenitz T., Brose N., Schwarzacher S.W. Neuroligin-1 regulates excitatory synaptic transmission, LTP and EPSP-spike coupling in the dentate gyrus in vivo. Brain Struct Funct 2015, 220:47-58.
110. Jiang Y.H., Ehlers M.D. Modeling autism by SHANK gene mutations in mice. Neuron 2013, 78:8-27.
111. Jiang Y.H., Armstrong D., Albrecht U., Atkins C.M., Noebels J.L., Eichele G., Sweatt J.D., Beaudet A.L. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 1998, 21:799-811.
112. Ju A., Hammerschmidt K., Tantra M., Krueger D., Brose N., Ehrenreich H. Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism. Behav Brain Res 2014, 270:159-164.
113. Jung S.Y., Kim J., Kwon O.B., Jung J.H., An K., Jeong A.Y., Lee C.J., Choi Y.B., Bailey C.H., Kandel E.R., Kim J.H. Input-specific synaptic plasticity in the amygdala is regulated by neuroligin-1 via postsynaptic NMDA receptors. Proc Natl Acad Sci USA 2010, 107:4710-4715.
114. Just M.A., Cherkassky V.L., Keller T.A., Minshew N.J. Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain 2004, 127:1811-1821.
115. Kana R.K., Uddin L.Q., Kenet T., Chugani D., Muller R.A. Brain connectivity in autism. Front Hum Neurosci 2014, 8:349.
116. Karayannis T., Au E., Patel J.C., Kruglikov I., Markx S., Delorme R., Heron D., Salomon D., Glessner J., Restituito S., Gordon A., Rodriguez-Murillo L., Roy N.C., Gogos J.A., Rudy B., Rice M.E., Karayiorgou M., Hakonarson H., Keren B., Huguet G., Bourgeron T., Hoeffer C., Tsien R.W., Peles E., Fishell G. Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature 2014, 511:236-240.
117. Karten A., Hirsch J. Brief report: anomalous neural deactivations and functional connectivity during receptive language in autism spectrum disorder: a functional MRI study. J Autism Dev Disord 2014, 45:1905-1914.
118. Keown C.L., Shih P., Nair A., Peterson N., Mulvey M.E., Muller R.A. Local functional overconnectivity in posterior brain regions is associated with symptom severity in autism spectrum disorders. Cell Reports 2013, 5:567-572.
119. Kim S., Chahrour M., Ben-Shachar S., Lim J. Ube3a/E6AP is involved in a subset of MeCP2 functions. Biochem Biophys Res Commun 2013, 437:67-73.
120. King M., Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol 2009, 38:1224-1234.
121. Kishino T., Lalande M., Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 1997, 15:70-73.
122. Kline D.D., Ogier M., Kunze D.L., Katz D.M. Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J Neurosci 2010, 30:5303-5310.
123. Kobayashi T., Minowa O., Kuno J., Mitani H., Hino O., Noda T. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res 1999, 59:1206-1211.
124. Kobayashi T., Minowa O., Sugitani Y., Takai S., Mitani H., Kobayashi E., Noda T., Hino O. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc Natl Acad Sci USA 2001, 98:8762-8767.
125. Koekkoek S.K., Yamaguchi K., Milojkovic B.A., Dortland B.R., Ruigrok T.J., Maex R., De Graaf W., Smit A.E., VanderWerf F., Bakker C.E., Willemsen R., Ikeda T., Kakizawa S., Onodera K., Nelson D.L., Mientjes E., Joosten M., De Schutter E., Oostra B.A., Ito M., De Zeeuw C.I. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron 2005, 47:339-352.
126. Kouser M., Speed H.E., Dewey C.M., Reimers J.M., Widman A.J., Gupta N., Liu S., Jaramillo T.C., Bangash M., Xiao B., Worley P.F., Powell C.M. Loss of predominant Shank3 isoforms results in hippocampus-dependent impairments in behavior and synaptic transmission. J Neurosci 2013, 33:18448-18468.
127. Kuhnle S., Mothes B., Matentzoglu K., Scheffner M. Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc. Proc Natl Acad Sci USA 2013, 110:8888-8893.
128. Kumar S., Talis A.L., Howley P.M. Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J Biol Chem 1999, 274:18785-18792.
129. Kwiatkowski D.J., Zhang H., Bandura J.L., Heiberger K.M., Glogauer M., el-Hashemite N., Onda H. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet 2002, 11:525-534.
130. Kwon C.H., Luikart B.W., Powell C.M., Zhou J., Matheny S.A., Zhang W., Li Y., Baker S.J., Parada L.F. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006, 50:377-388.
131. Kwon H.B., Kozorovitskiy Y., Oh W.J., Peixoto R.T., Akhtar N., Saulnier J.L., Gu C., Sabatini B.L. Neuroligin-1-dependent competition regulates cortical synaptogenesis and synapse number. Nat Neurosci 2012, 15:1667-1674.
132. Landi S., Putignano E., Boggio E.M., Giustetto M., Pizzorusso T., Ratto G.M. The short-time structural plasticity of dendritic spines is altered in a model of Rett syndrome. Sci Rep 2011, 1:45.
133. Lang M., Wither R.G., Colic S., Wu C., Monnier P.P., Bardakjian B.L., Zhang L., Eubanks J.H. Rescue of behavioral and EEG deficits in male and female Mecp2-deficient mice by delayed Mecp2 gene reactivation. Hum Mol Genet 2014, 23:303-318.
134. Lauterborn J.C., Rex C.S., Kramar E., Chen L.Y., Pandyarajan V., Lynch G., Gall C.M. Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J Neurosci 2007, 27:10685-10694.
135. Lee H.Y., Ge W.P., Huang W., He Y., Wang G.X., Rowson-Baldwin A., Smith S.J., Jan Y.N., Jan L.Y. Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein. Neuron 2011, 72:630-642.
136. Lee J., Chung C., Ha S., Lee D., Kim D.Y., Kim H., Kim E. Shank3-mutant mice lacking exon 9 show altered excitation/inhibition balance, enhanced rearing, and spatial memory deficit. Front Cell Neurosci 2015, 9:94.
137. Li J., Pelletier M.R., Perez Velazquez J.L., Carlen P.L. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol Cell Neurosci 2002, 19:138-151.
138. Liu K.Y., King M., Bearman P.S. Social influence and the autism epidemic. AJS 2010, 115:1387-1434.
139. Lonetti G., Angelucci A., Morando L., Boggio E.M., Giustetto M., Pizzorusso T. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol Psychiatry 2010, 67:657-665.
140. Lord C., Cook E.H., Leventhal B.L., Amaral D.G. Autism spectrum disorders. Neuron 2000, 28:355-363.
141. Louria-Hayon I., Alsheich-Bartok O., Levav-Cohen Y., Silberman I., Berger M., Grossman T., Matentzoglu K., Jiang Y.H., Muller S., Scheffner M., Haupt S., Haupt Y. E6AP promotes the degradation of the PML tumor suppressor. Cell Death Differ 2009, 16:1156-1166.
142. Lugo J.N., Smith G.D., Arbuckle E.P., White J., Holley A.J., Floruta C.M., Ahmed N., Gomez M.C., Okonkwo O. Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins. Front Mol Neurosci 2014, 7:27.
143. Luikart B.W., Schnell E., Washburn E.K., Bensen A.L., Tovar K.R., Westbrook G.L. Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J Neurosci 2011, 31:4345-4354.
144. Lyst M.J., Bird A. Rett syndrome: a complex disorder with simple roots. Nat Rev Genet 2015, 261-275.
145. Mabb A.M., Ehlers M.D. Ubiquitination in postsynaptic function and plasticity. Annu Rev Cell Dev Biol 2010, 26:179-210.
146. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998, 273:13375-13378.
147. Mani A., Oh A.S., Bowden E.T., Lahusen T., Lorick K.L., Weissman A.M., Schlegel R., Wellstein A., Riegel A.T. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res 2006, 66:8680-8686.
148. Matsuura T., Sutcliffe J.S., Fang P., Galjaard R.J., Jiang Y.H., Benton C.S., Rommens J.M., Beaudet A.L. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 1997, 15:74-77.
149. Maunakea A.K., Chepelev I., Cui K., Zhao K. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res 2013, 23:1256-1269.
150. McGraw C.M., Samaco R.C., Zoghbi H.Y. Adult neural function requires MeCP2. Science 2011, 333(6039):186. Epub 2011, Jun 2. 10.1126/science.1206593.
151. McMahon J.J., Yu W., Yang J., Feng H., Helm M., McMahon E., Zhu X., Shin D., Huang Y. Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice. Neurobiol Dis 2014, 73C:296-306.
152. Meyer G., Varoqueaux F., Neeb A., Oschlies M., Brose N. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology 2004, 47:724-733.
153. Miao S., Chen R., Ye J., Tan G.H., Li S., Zhang J., Jiang Y.H., Xiong Z.Q. The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons. J Neurosci 2013, 33:327-333.
154. Michalon A., Sidorov M., Ballard T.M., Ozmen L., Spooren W., Wettstein J.G., Jaeschke G., Bear M.F., Lindemann L. Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 2012, 74:49-56.
155. Mientjes E.J., Nieuwenhuizen I., Kirkpatrick L., Zu T., Hoogeveen-Westerveld M., Severijnen L., Rife M., Willemsen R., Nelson D.L., Oostra B.A. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo. Neurobiol Dis 2006, 21:549-555.
156. Minshew N.J., Keller T.A. The nature of brain dysfunction in autism: functional brain imaging studies. Curr Opin Neurol 2010, 23:124-130.
157. Missler M., Zhang W., Rohlmann A., Kattenstroth G., Hammer R.E., Gottmann K., Sudhof T.C. Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 2003, 423:939-948.
158. Miura K., Kishino T., Li E., Webber H., Dikkes P., Holmes G.L., Wagstaff J. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol Dis 2002, 9:149-159.
159. Moretti P., Levenson J.M., Battaglia F., Atkinson R., Teague R., Antalffy B., Armstrong D., Arancio O., Sweatt J.D., Zoghbi H.Y. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 2006, 26:319-327.
160. Mulherkar S.A., Sharma J., Jana N.R. The ubiquitin ligase E6-AP promotes degradation of alpha-synuclein. J Neurochem 2009, 110:1955-1964.
161. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88(4):471-481.
162. Napoli E., Ross-Inta C., Wong S., Hung C., Fujisawa Y., Sakaguchi D., Angelastro J., Omanska-Klusek A., Schoenfeld R., Giulivi C. Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. PLoS One 2012, 7:e42504.
163. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015, 18(2):199-209. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium.
164. Nevison C.D. A comparison of temporal trends in United States autism prevalence to trends in suspected environmental factors. Environ Health 2014, 13. 73-069X-13-73.
165. Ogier M., Wang H., Hong E., Wang Q., Greenberg M.E., Katz D.M. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J Neurosci 2007, 27:10912-10917.
166. Onda H., Lueck A., Marks P.W., Warren H.B., Kwiatkowski D.J. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest 1999, 104:687-695.
167. Pan F., Aldridge G.M., Greenough W.T., Gan W.B. Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA 2010, 107:17768-17773.
168. Paradee W., Melikian H.E., Rasmussen D.L., Kenneson A., Conn P.J., Warren S.T. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 1999, 94:185-192.
169. Peca J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., Lascola C.D., Fu Z., Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
170. Penagarikano O., Abrahams B.S., Herman E.I., Winden K.D., Gdalyahu A., Dong H., Sonnenblick L.I., Gruver R., Almajano J., Bragin A., Golshani P., Trachtenberg J.T., Peles E., Geschwind D.H. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011, 147:235-246.
171. Persico A.M., Napolioni V. Autism genetics. Behav Brain Res 2013, 251:95-112.
172. Peters S.U., Beaudet A.L., Madduri N., Bacino C.A. Autism in Angelman syndrome: implications for autism research. Clin Genet 2004, 66:530-536.
173. Pieretti M., Zhang F.P., Fu Y.H., Warren S.T., Oostra B.A., Caskey C.T., Nelson D.L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991, 66:817-822.
174. Pignatelli M., Piccinin S., Molinaro G., Di Menna L., Riozzi B., Cannella M., Motolese M., Vetere G., Catania M.V., Battaglia G., Nicoletti F., Nistico R., Bruno V. Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling Angelman syndrome. J Neurosci 2014, 34:4558-4566.
175. Pilpel Y., Kolleker A., Berberich S., Ginger M., Frick A., Mientjes E., Oostra B.A., Seeburg P.H. Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice. J Physiol 2009, 587:787-804.
176. Pizzarelli R., Cherubini E. Developmental regulation of GABAergic signalling in the hippocampus of neuroligin 3 R451C knock-in mice: an animal model of Autism. Front Cell Neurosci 2013, 7:85.
177. Potter C.J., Pedraza L.G., Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 2002, 4:658-665.
178. Rabaneda L.G., Robles-Lanuza E., Nieto-Gonzalez J.L., Scholl F.G. Neurexin dysfunction in adult neurons results in autistic-like behavior in mice. Cell Rep 2014, 8:338-346.
179. Radyushkin K., Hammerschmidt K., Boretius S., Varoqueaux F., El-Kordi A., Ronnenberg A., Winter D., Frahm J., Fischer J., Brose N., Ehrenreich H. Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav 2009, 8:416-425.
180. Reith R.M., McKenna J., Wu H., Hashmi S.S., Cho S.H., Dash P.K., Gambello M.J. Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex. Neurobiol Dis 2013, 51:93-103.
181. Robinson L., Guy J., McKay L., Brockett E., Spike R.C., Selfridge J., De Sousa D., Merusi C., Riedel G., Bird A., Cobb S.R. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 2012, 135:2699-2710.
182. Rothwell P.E., Fuccillo M.V., Maxeiner S., Hayton S.J., Gokce O., Lim B.K., Fowler S.C., Malenka R.C., Sudhof T.C. Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 2014, 158:198-212.
183. Rougeulle C., Glatt H., Lalande M. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat Genet 1997, 17:14-15.
184. Roussignol G., Ango F., Romorini S., Tu J.C., Sala C., Worley P.F., Bockaert J., Fagni L. Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J Neurosci 2005, 25:3560-3570.
185. Sato M., Stryker M.P. Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proc Natl Acad Sci USA 2010, 107:5611-5616.
186. Sato D., Lionel A.C., Leblond C.S., Prasad A., Pinto D., Walker S., O'Connor I., Russell C., Drmic I.E., Hamdan F.F., Michaud J.L., Endris V., Roeth R., Delorme R., Huguet G., Leboyer M., Rastam M., Gillberg C., Lathrop M., Stavropoulos D.J., Anagnostou E., Weksberg R., Fombonne E., Zwaigenbaum L., Fernandez B.A., Roberts W., Rappold G.A., Marshall C.R., Bourgeron T., Szatmari P., Scherer S.W. SHANK1 deletions in males with autism spectrum disorder. Am J Hum Genet 2012, 90:879-887.
187. Scheiffele P., Fan J., Choih J., Fetter R., Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000, 101:657-669.
188. Schmeisser M.J., Ey E., Wegener S., Bockmann J., Stempel A.V., Kuebler A., Janssen A.L., Udvardi P.T., Shiban E., Spilker C., Balschun D., Skryabin B.V., Dieck S., Smalla K.H., Montag D., Leblond C.S., Faure P., Torquet N., Le Sourd A.M., Toro R., Grabrucker A.M., Shoichet S.A., Schmitz D., Kreutz M.R., Bourgeron T., Gundelfinger E.D., Boeckers T.M. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 2012, 486:256-260.
189. Schutt J., Falley K., Richter D., Kreienkamp H.J., Kindler S. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities. J Biol Chem 2009, 284:25479-25487.
190. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
191. Sharma A., Hoeffer C.A., Takayasu Y., Miyawaki T., McBride S.M., Klann E., Zukin R.S. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 2010, 30:694-702.
192. Sheng M., Kim E. The Shank family of scaffold proteins. J Cell Sci 2000, 113(Pt 11):1851-1856.
193. Sidorov M.S., Auerbach B.D., Bear M.F. Fragile X mental retardation protein and synaptic plasticity. Mol Brain 2013, 8(6):15.
194. Silva-Santos S., van Woerden G.M., Bruinsma C.F., Mientjes E., Jolfaei M.A., Distel B., Kushner S.A., Elgersma Y. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model. J Clin Invest 2015, 125:2069-2076.
195. Silverman J.L., Yang M., Lord C., Crawley J.N. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 2010, 11:490-502.
196. Silverman J.L., Turner S.M., Barkan C.L., Tolu S.S., Saxena R., Hung A.Y., Sheng M., Crawley J.N. Sociability and motor functions in Shank1 mutant mice. Brain Res 2011, 1380:120-137.
197. Silverman J.L., Smith D.G., Rizzo S.J., Karras M.N., Turner S.M., Tolu S.S., Bryce D.K., Smith D.L., Fonseca K., Ring R.H., Crawley J.N. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med 2012, 4:131ra51.
198. Smalley S.L., Tanguay P.E., Smith M., Gutierrez G. Autism and tuberous sclerosis. J Autism Dev Disord 1992, 22:339-355.
199. Smith S.E., Zhou Y.D., Zhang G., Jin Z., Stoppel D.C., Anderson M.P. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci Transl Med 2011, 3:103ra97.
200. Smrt R.D., Eaves-Egenes J., Barkho B.Z., Santistevan N.J., Zhao C., Aimone J.B., Gage F.H., Zhao X. Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol Dis 2007, 27:77-89.
201. Speed H.E., Kouser M., Xuan Z., Reimers J.M., Ochoa C.F., Gupta N., Liu S., Powell C.M. Autism-associated insertion mutation (InsG) of Shank3 exon 21 causes impaired synaptic transmission and behavioral deficits. J Neurosci 2015, 35:9648-9665.
202. Sperow M., Berry R.B., Bayazitov I.T., Zhu G., Baker S.J., Zakharenko S.S. Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration. J Physiol 2012, 590:777-792.
203. Steinberg K.M., Ramachandran D., Patel V.C., Shetty A.C., Cutler D.J., Zwick M.E. Identification of rare X-linked neuroligin variants by massively parallel sequencing in males with autism spectrum disorder. Mol Autism 2012, 3. 8-2392-3-8.
204. Sungur A.O., Vorckel K.J., Schwarting R.K., Wohr M. Repetitive behaviors in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context. J Neurosci Methods 2014, 234:92-100.
205. Supekar K., Uddin L.Q., Khouzam A., Phillips J., Gaillard W.D., Kenworthy L.E., Yerys B.E., Vaidya C.J., Menon V. Brain hyperconnectivity in children with autism and its links to social deficits. Cell Rep 2013, 5:738-747.
206. Suzuki A., de la Pompa J.L., Stambolic V., Elia A.J., Sasaki T., del Barco Barrantes I., Ho A., Wakeham A., Itie A., Khoo W., Fukumoto M., Mak T.W. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 1998, 8:1169-1178.
207. Tabuchi K., Sudhof T.C. Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 2002, 79:849-859.
208. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Sudhof T.C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
209. Takeuchi K., Gertner M.J., Zhou J., Parada L.F., Bennett M.V., Zukin R.S. Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism. Proc Natl Acad Sci USA 2013, 110:4738-4743.
210. Tang S.J., Reis G., Kang H., Gingras A.C., Sonenberg N., Schuman E.M. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci USA 2002, 99:467-472.
211. Tang G., Gudsnuk K., Kuo S.H., Cotrina M.L., Rosoklija G., Sosunov A., Sonders M.S., Kanter E., Castagna C., Yamamoto A., Yue Z., Arancio O., Peterson B.S., Champagne F., Dwork A.J., Goldman J., Sulzer D. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 2014, 83:1131-1143.
212. Tavazoie S.F., Alvarez V.A., Ridenour D.A., Kwiatkowski D.J., Sabatini B.L. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 2005, 8:1727-1734.
213. Tee A.R., Manning B.D., Roux P.P., Cantley L.C., Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 2003, 13:1259-1268.
214. The Dutch-Belgian Fragile X Consortium Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 1994, 78:23-33.
215. Tilot A.K., Gaugler M.K., Yu Q., Romigh T., Yu W., Miller R.H., Frazier T.W., Eng C. Germline disruption of Pten localization causes enhanced sex-dependent social motivation and increased glial production. Hum Mol Genet 2014, 23:3212-3227.
216. Treutlein B., Gokce O., Quake S.R., Sudhof T.C. Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing. Proc Natl Acad Sci USA 2014, 111:E1291-E1299.
217. Tsai P.T., Hull C., Chu Y., Greene-Colozzi E., Sadowski A.R., Leech J.M., Steinberg J., Crawley J.N., Regehr W.G., Sahin M. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 2012, 488:647-651.
218. Uddin L.Q., Supekar K., Menon V. Reconceptualizing functional brain connectivity in autism from a developmental perspective. Front Hum Neurosci 2013, 7:458.
219. Ullrich B., Ushkaryov Y.A., Sudhof T.C. Cartography of neurexins: more than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons. Neuron 1995, 14:497-507.
220. Vaags A.K., Lionel A.C., Sato D., Goodenberger M., Stein Q.P., Curran S., Ogilvie C., Ahn J.W., Drmic I., Senman L., Chrysler C., Thompson A., Russell C., Prasad A., Walker S., Pinto D., Marshall C.R., Stavropoulos D.J., Zwaigenbaum L., Fernandez B.A., Fombonne E., Bolton P.F., Collier D.A., Hodge J.C., Roberts W., Szatmari P., Scherer S.W. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet 2012, 90:133-141.
221. van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., Lindhout D., van den Ouweland A., Halley D., Young J., Burley M., Jeremiah S., Woodward K., Nahmias J., Fox M., Ekong R., Osborne J., Wolfe J., Povey S., Snell R.G., Cheadle J.P., Jones A.C., Tachataki M., Ravine D., Sampson J.R., Reeve M.P., Richardson P., Wilmer F., Munro C., Hawkins T.L., Sepp T., Ali J.B., Ward S., Green A.J., Yates J.R., Kwiatkowska J., Henske E.P., Short M.P., Haines J.H., Jozwiak S., Kwiatkowski D.J. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997, 277:805-808.
222. Varoqueaux F., Aramuni G., Rawson R.L., Mohrmann R., Missler M., Gottmann K., Zhang W., Sudhof T.C., Brose N. Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
223. Verkerk A.J., Pieretti M., Sutcliffe J.S., Fu Y.H., Kuhl D.P., Pizzuti A., Reiner O., Richards S., Victoria M.F., Zhang F.P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65:905-914.
224. Vissers M.E., Cohen M.X., Geurts H.M. Brain connectivity and high functioning autism: a promising path of research that needs refined models, methodological convergence, and stronger behavioral links. Neurosci Biobehav Rev 2012, 36:604-625.
225. Wallace M.L., Burette A.C., Weinberg R.J., Philpot B.D. Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron 2012, 74:793-800.
226. Wang Y., Cheng A., Mattson M.P. The PTEN phosphatase is essential for long-term depression of hippocampal synapses. Neuromolecular Med 2006, 8:329-336.
227. Wang X., McCoy P.A., Rodriguiz R.M., Pan Y., Je H.S., Roberts A.C., Kim C.J., Berrios J., Colvin J.S., Bousquet-Moore D., Lorenzo I., Wu G., Weinberg R.J., Ehlers M.D., Philpot B.D., Beaudet A.L., Wetsel W.C., Jiang Y.H. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet 2011, 20:3093-3108.
228. Wang X., Xu Q., Bey A.L., Lee Y., Jiang Y.H. Transcriptional and functional complexity of Shank3 provides a molecular framework to understand the phenotypic heterogeneity of SHANK3 causing autism and Shank3 mutant mice. Mol Autism 2014, 5. 30-2392-5-30. eCollection 2014.
229. Weeber E.J., Jiang Y.H., Elgersma Y., Varga A.W., Carrasquillo Y., Brown S.E., Christian J.M., Mirnikjoo B., Silva A., Beaudet A.L., Sweatt J.D. Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J Neurosci 2003, 23:2634-2644.
230. Weston M.C., Chen H., Swann J.W. Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures. Front Mol Neurosci 2014, 7:1.
231. Williams M.R., DeSpenza T., Li M., Gulledge A.T., Luikart B.W. Hyperactivity of newborn Pten knock-out neurons results from increased excitatory synaptic drive. J Neurosci 2015, 35:943-959.
232. Willner P. The validity of animal models of depression. Psychopharmacology 1984, 83:1-16.
233. Willsey A.J., State M.W. Autism spectrum disorders: from genes to neurobiology. Curr Opin Neurobiol 2015, 30:92-99.
234. Wilson H.L., Wong A.C., Shaw S.R., Tse W.Y., Stapleton G.A., Phelan M.C., Hu S., Marshall J., McDermid H.E. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 2003, 40:575-584.
235. Wilson C., Idziaszczyk S., Parry L., Guy C., Griffiths D.F., Lazda E., Bayne R.A., Smith A.J., Sampson J.R., Cheadle J.P. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma. Hum Mol Genet 2005, 14:1839-1850.
236. Wohr M., Roullet F.I., Hung A.Y., Sheng M., Crawley J.N. Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One 2011, 6:e20631.
237. Wohr M., Silverman J.L., Scattoni M.L., Turner S.M., Harris M.J., Saxena R., Crawley J.N. Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2. Behav Brain Res 2013, 251:50-64.
238. Won H., Lee H.R., Gee H.Y., Mah W., Kim J.I., Lee J., Ha S., Chung C., Jung E.S., Cho Y.S., Park S.G., Lee J.S., Lee K., Kim D., Bae Y.C., Kaang B.K., Lee M.G., Kim E. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 2012, 486:261-265.
239. Yamasaki K., Joh K., Ohta T., Masuzaki H., Ishimaru T., Mukai T., Niikawa N., Ogawa M., Wagstaff J., Kishino T. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum Mol Genet 2003, 12:837-847.
240. Yashiro K., Riday T.T., Condon K.H., Roberts A.C., Bernardo D.R., Prakash R., Weinberg R.J., Ehlers M.D., Philpot B.D. Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci 2009, 12:777-783.
241. Yasuda S., Sugiura H., Katsurabayashi S., Shimada T., Tanaka H., Takasaki K., Iwasaki K., Kobayashi T., Hino O., Yamagata K. Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex. Sci Rep 2014, 4:5155.
242. Young J.I., Hong E.P., Castle J.C., Crespo-Barreto J., Bowman A.B., Rose M.F., Kang D., Richman R., Johnson J.M., Berget S., Zoghbi H.Y. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci USA 2005, 102:17551-17558.
243. Zaaroor-Regev D., de Bie P., Scheffner M., Noy T., Shemer R., Heled M., Stein I., Pikarsky E., Ciechanover A. Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome. Proc Natl Acad Sci USA 2010, 107:6788-6793.